LENSAR Inc (LNSR)
LENSAR, Inc. is a commercial-stage medical device company listed on the NASDAQ under the ticker LNSR. As a common stock issuer in the healthcare equipment and supplies sector, the company develops and markets laser-based systems used in cataract treatment and in the management of pre-existing or surgically induced corneal astigmatism. Its product lineup includes the LENSAR Laser System, which uses proprietary technologies to support surgical imaging, procedure planning, and precision, as well as the ALLY Robotic Cataract Laser System, a compact platform designed for sterile laser-assisted cataract surgery in a single operating room. Incorporated in 2004, LENSAR is headquartered in Orlando, Florida, and serves markets in the United States, Europe, Asia, South Korea, and other international regions.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-LNSR
|
$6.18
|
7.7% Upside
|
Fair
|
$8.50
|
48.1% Upside
|
Undervalued
|
Good
|
—
|
—
|
—
|
0.0%
|
August 6, 2026
|
2.4x
|
6.5x
|
1.2x
|
70.619 M
|
73.359 M
|
3.0%
|
72.0%
|
-2.1
|
—
|
-41.6%
|
